Role of Hypercytokinemia/hyperchemokinemia in the Pathogenesis of Influenza |
3.16 |
Systemic Lupus Erythematosus In B Cell Signaling Pathway |
2.83 |
Interferon Signaling |
2.53 |
IL-17 Signaling |
2.45 |
Role of MAPK Signaling in Inhibiting the Pathogenesis of Influenza |
2.24 |
Regulation Of The Epithelial Mesenchymal Transition By Growth Factors Pathway |
2.00 |
Estrogen Receptor Signaling |
2.00 |
HIF1α Signaling |
2.00 |
Activation of IRF by Cytosolic Pattern Recognition Receptors |
1.34 |
Tumor Microenvironment Pathway |
1.34 |
Hepatic Fibrosis Signaling Pathway |
1.34 |
Acute Phase Response Signaling |
1.00 |
MSP-RON Signaling In Macrophages Pathway |
1.00 |
Leukocyte Extravasation Signaling |
1.00 |
Adrenomedullin signaling pathway |
1.00 |
Colorectal Cancer Metastasis Signaling |
1.00 |
Dendritic Cell Maturation |
1.00 |
Neuroinflammation Signaling Pathway |
0.82 |
Coronavirus Pathogenesis Pathway |
0.33 |
Sirtuin Signaling Pathway |
-1.34 |